Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$93M
14 rounds on record
Latest round
Venture round
Jul 2026 · 3 mo ago
Grants
$14.8M
3 grants · CORDIS
Backers
6
Wing Venture Capital, DCVC
The money's age
Fresh money
3 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 24 Raised a round Venture round Feb 25 Partnership Chemify and Sanacor Collaborate to Discover and Develop Small Molecule Therapies for Cardiometabolic Diseases February 25, 2026 Business Wire · businesswire.com Feb 24 Raised a round Venture round Oct 21, 2025 Raised a round Series B $50M · Chemical & Engineering News Jun 1, 2025 Raised a round Venture round Apr 1, 2025 Won a grant $5.1M · CORDIS Jan 7, 2025 Raised a round Venture round Oct 1, 2024 Raised a round Venture round Aug 14, 2024 New executive Chemify hires Kevin McGowan as Chief Business Officer August 14, 2024 Business Wire · businesswire.com Jun 18, 2024 Raised a round Venture round Jan 17, 2024 Partnership Chemify And Prepaire Labs Partner To Apply Chemistry AI-Robotics To Accelerate Discovery Of Non-Addictive Opioids · menafn.com Aug 1, 2023 Raised a round Series A $43M Jul 13, 2023 Raised a round Venture round Apr 1, 2023 Won a grant $9.6M · CORDIS Sep 1, 2022 Won a grant $111k · CORDIS Mar 11, 2022 Raised a round Venture round 2022 Founded Oct 19, 2021 Raised a round Venture round Oct 24, 2019 Incorporated CHEMIFY LIMITED · Companies House
Tractionpublic signals, read monthly
Web presence
top 2%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2026 — — find-and-update.company-information.service.gov.uk
Venture round Feb 2026 — — find-and-update.company-information.service.gov.uk
Series B Oct 2025 $50M — Chemical & Engineering News
Venture round Jun 2025 — — find-and-update.company-information.service.gov.uk
Grant Apr 2025 $5.1M — CORDIS
Venture round Jan 2025 — — find-and-update.company-information.service.gov.uk
Venture round Oct 2024 — — find-and-update.company-information.service.gov.uk
Venture round Jun 2024 — — find-and-update.company-information.service.gov.uk
Series A Aug 2023 $43M — bbc.com
Venture round Jul 2023 — — find-and-update.company-information.service.gov.uk
Grant Apr 2023 $9.6M — CORDIS
Grant Sep 2022 $111k — CORDIS
Venture round Mar 2022 — — find-and-update.company-information.service.gov.uk
Venture round Oct 2021 — — find-and-update.company-information.service.gov.uk
Registers and programsofficial lists and records that name the company
Legal entity CHEMIFY LIMITED Companies House
Registered 24 Oct 2019
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Kimia51-200 employees
Generating a chemical atlas for treating human disease. Our ATLAS technology merges AcTive® Learning with Automated Synthesis and…
1859Venture round $40M · 4 yr ago • Founded 2019 • 51-200 employees
1859 integrates combinatorial chemistry, pico-scale activity-based screening and machine learning to generate millions of empirical…
Firstlook AI builds PRISM, predictive intelligence for critical infrastructure. Built in Dallas by a team out of clinical machine learning…
Avicenna Biosciences is a drug development company using machine learning-enhanced medicinal chemistry to accelerate the lead-to-candidate…
Wayfinder Biosciences develops RNA-targeting small molecules for undruggable targets.
NEVER OUT OF DATE. High-quality Machine Learning Products & Solutions for High Performance Standards.

Visa sponsorship

  • United Kingdom · Licensed UK visa sponsor (Skilled Worker)

Visa details by country

Overview

Chemify builds a programmable chemistry platform that turns digital molecule designs into synthesis. Its chemputer robots execute code generated procedures. The company spun out of the University of Glasgow.

News

News ukbiotechday.org 5 months ago
UK Biotech Day - Where UK Biotech Meets the World
UK Biotech Day connects pharma, biotech, medtech, investors, and service providers for dealmaking, networking, and innovation in the UK and global life sciences sector.
Read more
Report
News Insights 6 months ago
Chemify Is Selling Infrastructure, Not Molecules - And Pharma Is Buying
Chemify's programmable chemistry platform - built around a proprietary language that constrains AI to synthesizable molecules - has secured peer-reviewed validation and 10 big pharma clients. CEO Lee Cronin is positioning the company as chemistry infrastr
Read more
Report
News manchempharma 6 months ago
Chemify founder publishes three papers validating Chemputation platform for automated drug discovery
Lee Cronin, CEO of deep-tech company Chemify, has published three papers in PNAS, Nature Communications Chemistry and Nature Communications Biology, demonstrating how Chemputation can digitise chemistry
Read more
Report
News Drug Discovery World (DDW) 6 months ago
Chemify'sdrug discovery platformvalidatedby papers
A platform helping drug discovery companies take a novel concept to makeable compound has beenvalidatedin three academic papers.
Read more
Report
News FutureScot 6 months ago
AI-powered chemistry technique born in Glasgow 'validated' by leading journals - heralding new dawn for drug discovery
AI-powered chemistry technique born in Glasgow 'validated' by leading journals - heralding new dawn for drug discovery
Read more
Report
News smgconferences.com 7 months ago
AI in Drug Discovery
SAE is proud to present the 8th Annual AI in Drug Discovery Conference on 8th - 10th of March 2027
Read more
Report
Show more news

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Glasgow United Kingdom
HQ
Where to find us
11 Chapel Lane, Glasgow G11 6EW
company site

Financials

Total raised
$107.8M
Latest round
Venture - Series Unknown
Funding rounds
14
Funding rounds
Round Announced Amount
Venture - Series Unknown 2026 — Details
Venture - Series Unknown 2026 — Details
Series B 2025 $50M Details
Venture - Series Unknown 2025 — Details
Grant 2025 $5.1M Details
Venture - Series Unknown 2025 — Details
Venture - Series Unknown 2024 — Details
Venture - Series Unknown 2024 — Details
Series A 2023 $43M Details
Venture - Series Unknown 2023 — Details
Grant 2023 $9.6M Details
Grant 2022 $111k Details
Venture - Series Unknown 2022 — Details
Venture - Series Unknown 2021 — Details